Published project 01
Merck & Co. (MSD)
Clinical study report authoring
Agency contribution
McKinsey's account credits QuantumBlack's AI and data-science expertise in a jointly developed clinical-study-report authoring application, alongside process redesign, role changes and upskilling. Medical writers review the drafts.
Delivery scope & limits
Merck's 25 June 2025 release confirms an implemented platform and the first live clinical study report submissions earlier that year. Wider rollout was still planned; current coverage has not been independently checked.
Historical work · 2025
The client links to the McKinsey collaboration but does not separately identify QuantumBlack's contribution; the unit's role remains provider-attributed.
Medical writers retain oversight. Live report submissions do not establish regulatory acceptance, clinical efficacy or improved patient outcomes.
Reported productivity and error-reduction figures are not independently audited here. Planned broader rollout is not evidence of completed or current coverage.
